The noose is drawing ever-tighter around Theranos. The Wall Street Journal is reporting the San Francisco hedge fund Partner Fund Management is suing the company and its founder, Elizabeth Holmes, for "engaging in securities fraud and other violations," according to a document reviewed by the Journal. The fund has invested nearly $100 million in Theranos, the paper says.
The company is already being sued by patients seeking class-action status in complaints related to inaccurate blood tests.
Last week, Theranos said it was getting out of the consumer blood-testing business, shutting down a handful of remaining blood-testing centers and shuttering its labs.
Read the Journal story below ...